Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,007 INR | +0.77% | +1.43% | +46.16% |
06:13am | Zydus Gets Four Observations from US FDA for Oncology Injectable Plant | MT |
Mar. 18 | Zydus Lifesciences Gets US FDA's Final Nod for Finasteride and Tadalafil Capsules | MT |
Evolution of the average Target Price on Zydus Lifesciences Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Zydus Lifesciences Limited
Jefferies & Co. | |
Nomura |
EPS Revisions
- Stock
- Equities
- Stock Zydus Lifesciences Limited - NSE India S.E.
- Consensus Zydus Lifesciences Limited